Ticker Symbol: ADAG
Adagene Inc - ADR
$9.65 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
China (Mainland)
Currency:
USD
Asset
Type: ADR
CIK:0001818838
Company Profile
adagene was co-founded by two serial entrepreneurs to power antibody discovery. its aim is to become the leading player in antibody discovery and engineering. it has developed a proprietary dynamic precision library (dpl) and is showcasing the power of the library with a unique pipeline of innovative antibody therapeutics that is advancing into clinical trials. adagene previously has raised three series of financing with over $86 million. investors include f-prime capital (formerly fidelity biosciences), eight roads ventures china (formerly fidelity growth partners asia), 6 dimensions capital, gp healthcare capital, sequoia china, and new world tmt. for more information, please visit www.adagene.com.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 4f, Building C14, No. 218,
Website: https://www.adagene.com/
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $1.40
Change:
-
(
0.00%)
Days Range: $1.36 - $1.43
Beta: -
52wk. High: $2.10
52wk. Low: $0.90
Ytd. Change 5.66%
50 Day Moving Average: $1.43
200 Day Moving Average: $1.38
Shares Outstanding: 43834671
Valuation
Market Cap: 6.1B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A